RecruitingObservational

Protocol to Permit Collection of Circulating Biomarkers in Pancreatic Cancer

NCT ID: NCT05743049Sponsor: Abramson Cancer Center at Penn MedicineLast updated: 2026-04-07

Summary

This protocol will involve collection of blood samples from patients with a diagnosis of pancreatic adenocarcinoma for evaluation of circulating biomarkers.

Arms & interventions

OtherObtaining blood for analysis of various circulating biomarkers
4 tbsp of blood in a 1-week period, occurring no more frequently than 4 times in an 8-week period

Outcome measures

Primary

To create a comprehensive system to collect, catalogue and store blood specimens from subjects with pancreatic cancer for future research use.
Time frame: Through study completion, an average of 1 year

Secondary

To create a computerized clinical data set from subjects with pancreatic cancer that contains information related to the subject's general health, disease status, treatments, and response.
Time frame: Through study completion, an average of 1 year
To integrate the data and specimens to permit the most informative clinical-biologic research platform.
Time frame: Through study completion, an average of 1 year

Eligibility criteria

Sex: AllAge: 18 Years and olderHealthy volunteers: No

Inclusion Criteria: * The subject must have a known or presumed diagnosis of pancreatic adenocarcinoma * The subject must be a patient of the University of Pennsylvania * The subject must be able to provide informed consent * The subject must be 18 years of age or older Exclusion Criteria: . Subjects who have any clinically significant psychiatric, social, or medical condition that, in the opinion of the investigator, could increase the patient's risk, interfere with protocol adherence, or affect the patient's ability to give informed consent are ineligible to participate in the study.

Study locations (1)

Abramson Cancer Center at University of Pennsylvania

Philadelphia, Pennsylvania, 19104

Recruiting